Filing Details
- Accession Number:
- 0001127602-10-011087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-14 13:00:00
- Reporting Period:
- 2010-04-12
- Filing Date:
- 2010-04-14
- Accepted Time:
- 2010-04-14 15:16:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410397 | Stuart Grant | 2190 Parkway Lake Drive Birmingham AL 35244- | Sr Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-12 | 509 | $3.26 | 12,226 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-12 | 509 | $8.26 | 11,717 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Emp. Stock Option (Right to Buy) | Disposition | 2010-04-12 | 509 | $0.00 | 509 | $3.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
74,491 | 2009-03-14 | 2018-03-14 | No | 4 | M | Direct |
Footnotes
- Transacted under a 10b5-1 plan that was adopted on 11/23/2009.